1 Heterologous desensitization or intermolecular cross-talk plays a critical role in regulating intracellular signalling by diverse members of the G-protein-coupled receptor superfamily. We have previously established that the a and b isoforms of the human thromboxane A 2 receptor (TP) undergo differential desensitization of signalling in response to 17 phenyl trinor prostaglandin (PG)E 2 , an agonist of the EP 1 subtype of the PGE 2 receptor (EP) family. 2 Herein, we investigated the molecular basis of TPa and TPb desensitization in human embryonic kidney (HEK) 293 cells and in renal mesangial cells in response to 17 phenyl trinor PGE 2 and in response to the PGF 2a receptor (FP) agonist PGF 2a , and sought to identify the target site(s) of those desensitizations.3 Our results demonstrated that TPa and TPb receptors are subject to desensitization in response to both EP 1 and FP receptor activation and that these effects are mediated by direct protein kinase (PK)C phosphorylation of the individual TP isoforms within their unique carboxyl-terminal (C)-tail domains. 4 Moreover, deletion/site-directed mutagenesis and metabolic labelling studies identified Thr 337 , within TPa, and Thr 399 , within TPb, as the specific target residues for PKC phosphorylation and EP 1 -and FP-mediated desensitization of TPa and TPb signalling, respectively. 5 Hence, in conclusion, while the TPa and TPb diverge within their C-tail domains, they have evolved to share a similar mechanism of PKC-induced phosphorylation and desensitization in response to EP 1 and FP receptor activation, though it occurs at sites unique to the individual TP isoforms.